A flurry of new studies suggest scientists are finally figuring out how to harness the immune system to attack a ruthless form of brain cancer. While preliminary, the results offer hope that progress is possible against glioblastoma, ...
Mar 23, 2024
0
1
Foundation models, advanced artificial intelligence systems trained on large-scale datasets, hold the potential to provide unprecedented advancements for the medical field. In computational pathology (CPath), these models ...
Mar 19, 2024
0
63
One of the most touted promises of medical artificial intelligence tools is their ability to augment human clinicians' performance by helping them interpret images such as X-rays and CT scans with greater precision to make ...
Mar 19, 2024
0
30
A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Mar 14, 2024
0
20
Targeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain ...
Mar 13, 2024
0
89
A pioneering Phase I CAR T cell therapy trial for the treatment of glioblastoma at City of Hope demonstrates promising clinical activity against incurable brain tumors, according to research published in Nature Medicine.
Mar 7, 2024
0
16
A few years ago, researchers made the unnerving discovery that in the brains of people with Alzheimer's disease, disordered clumps of abnormal proteins had been growing for 15 or even 20 years before their diagnosis. That ...
Mar 7, 2024
0
1
Common inherited genetic factors that predict cancer risk in the general population may also predict elevated risk of new cancers among childhood cancer survivors, according to a study led by researchers at the National Cancer ...
Mar 7, 2024
0
10
Scientists have created miniorgans from cells floating in the fluid that surrounds a fetus in the womb—an advance they believe could open up new areas of prenatal medicine.
Mar 4, 2024
0
1
The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract cancers and melanoma.
Mar 1, 2024
0
92
